Skip to content
The Nexus
DossierENTITY

Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act

Coverage of Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act in the Nexus archive.

Earliest in view: Aug 14 · 07:30 UTCMost recent: Aug 14 · 07:30 UTC
Co-mentioned in this coverage
National Association of Boards of Pharmacyorganization1U.S. Food and Drug Administrationorganization1Louisianaplace1Cancer Medicinestopic1pharmaceutical supply chaintopic1
Recent coverage
  • HEALTHAug 14 · 07:30 UTCOHIO CAPITAL JOURNAL
    Cancer patients deserve peace of mind when it comes to medication

    Cancer medicine treatments face pharmaceutical supply chain challenges, including drug shortages and reports of counterfeit medicines reaching U.S. clinics. Efforts to strengthen safety involve legislative solutions like the proposed Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act and regulatory improvements by organizations such as NABP. Furthermore, patient education is stressed as essential so that individuals understand if a medication is FDA-approved or compounded for an individual need.

Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act · Dossier · The Nexus